Soleno Therapeutics (SLNO) Share-based Compensation Growth (5y) (2018 - 2026)
Soleno Therapeutics (SLNO) Share-based Compensation Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Soleno Therapeutics |
2.76 Bn |
2.51 Bn |
93.41 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
71.10% |
| Dec 31, 2025 |
96.35% |
| Sep 30, 2025 |
92.93% |
| Jun 30, 2025 |
95.34% |
| Mar 31, 2025 |
106.39% |
| Dec 31, 2024 |
170.89% |
| Sep 30, 2024 |
226.30% |
| Jun 30, 2024 |
100.68% |
| Mar 31, 2024 |
91.85% |
| Dec 31, 2023 |
30.16% |
| Sep 30, 2023 |
56.96% |
| Jun 30, 2023 |
43.34% |
| Mar 31, 2023 |
13.10% |
| Dec 31, 2022 |
34.24% |
| Sep 30, 2022 |
24.76% |
| Jun 30, 2022 |
5.21% |
| Mar 31, 2022 |
28.33% |
| Dec 31, 2021 |
7.26% |
| Sep 30, 2021 |
34.48% |
| Jun 30, 2021 |
31.49% |
